Percent reduction in proptosis after teprotumumab treatment for thyroid eye disease.

چکیده

Prior studies of teprotumumab for thyroid eye disease report proptosis reduction in millimetres, which does not fully capture teprotumumab's clinical effect since a given number of millimetres change can be of variable impact depending on patients' degree of pre-treatment proptosis. In this…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• بیماری چشمی تیروئید